Menatetrenone

四烯甲萘醌

Report date: 2022/09/22 17:48:02
NME

Base Information

Drug NameMenatetrenone
Drug Alias NamemenatetrenonummenatetrenonaMenaquinonegoldGlakay (osteoporosis)Kaytwo (vitamin K deficiency) +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteogenesis stimulants
TargetsNot applicable
Therapy Area/IndicationsPainPostoperative ComplicationsHemorrhage +[6] 
Global Approved IndicationsPainHemorrhage
Approved Indications in ChinaPain
Original Approved Country/TerritoryN/A
Original Approved Date1972/01/01
Country/TerritorySingaporeMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNational University Health SystemEisai Co Ltd
Inactive CompaniesEisai Ltd
Active IndicationsPainPostoperative ComplicationsHemorrhage +[5] 
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeM05BX08
Related LinksWikipediaKEGG